BRI Biopharmaceutical Research Inc. is a specialized analytical, bioanalytical and DM/PK contract research organization (CRO) servicing pharmaceutical and biotechnology companies in discovery, preclinical and clinical programs supporting IND and NDA-enabling studies.BRI is a contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs. BRI is accredited by Standard Council of Canada for its GLP compliance. Its successful track record in providing accurate and quality data in conformance with GLP, GCP and cGMP regulations within USFDA, OECD and MHLW (Japan) ensures that you achieve your development goals.